UBS Group’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,945
| Closed | -$17.5K | – | 9605 |
|
|
2025
Q1 | $17.5K | Buy |
29,945
+29,900
| +66,444% | +$17.4K | ﹤0.01% | 7015 |
|
|
2024
Q4 | $513 | Buy |
+45
| New | +$513 | ﹤0.01% | 8194 |
|
|
2024
Q3 | – | Sell |
-778
| Closed | -$8.75K | – | 8908 |
|
|
2024
Q2 | $8.75K | Buy |
778
+728
| +1,456% | +$8.19K | ﹤0.01% | 6624 |
|
|
2024
Q1 | $552 | Buy |
+50
| New | +$552 | ﹤0.01% | 7308 |
|
|
2023
Q4 | – | Sell |
-60
| Closed | -$650 | – | 8684 |
|
|
2023
Q3 | $650 | Buy |
+60
| New | +$650 | ﹤0.01% | 7204 |
|
|
2022
Q4 | – | Sell |
-49,006
| Closed | -$497K | – | 9894 |
|
|
2022
Q3 | $497K | Buy |
49,006
+221
| +0.5% | +$2.24K | ﹤0.01% | 3381 |
|
|
2022
Q2 | $487K | Buy |
+48,785
| New | +$487K | ﹤0.01% | 3360 |
|